ZA942686B - Active compound from a sponge - Google Patents

Active compound from a sponge

Info

Publication number
ZA942686B
ZA942686B ZA942686A ZA942686A ZA942686B ZA 942686 B ZA942686 B ZA 942686B ZA 942686 A ZA942686 A ZA 942686A ZA 942686 A ZA942686 A ZA 942686A ZA 942686 B ZA942686 B ZA 942686B
Authority
ZA
South Africa
Prior art keywords
sponge
active compound
compound
palau
affections
Prior art date
Application number
ZA942686A
Other languages
English (en)
Inventor
Robin Bryan Kinnel
Paul Joseph Scheuer
Glynn Thomas Faircloth
Henning-Peter Gehrken
Dolores Garcia Gravalos
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of ZA942686B publication Critical patent/ZA942686B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA942686A 1993-04-20 1994-04-19 Active compound from a sponge ZA942686B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939308111A GB9308111D0 (en) 1993-04-20 1993-04-20 Active compound from a stonge

Publications (1)

Publication Number Publication Date
ZA942686B true ZA942686B (en) 1995-07-21

Family

ID=10734127

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA942686A ZA942686B (en) 1993-04-20 1994-04-19 Active compound from a sponge

Country Status (11)

Country Link
US (2) US20020062023A1 (de)
EP (1) EP0626383B1 (de)
JP (1) JP3489635B2 (de)
AT (1) ATE171180T1 (de)
AU (1) AU672098B2 (de)
CA (1) CA2121613A1 (de)
DE (1) DE69413302T2 (de)
DK (1) DK0626383T3 (de)
ES (1) ES2124844T3 (de)
GB (1) GB9308111D0 (de)
ZA (1) ZA942686B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1152050C (zh) * 2001-07-12 2004-06-02 中国人民解放军第二军医大学 一种新的具有抗癌活性的环肽类化合物phakellistatin 12
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Also Published As

Publication number Publication date
AU672098B2 (en) 1996-09-19
DK0626383T3 (da) 1999-06-14
DE69413302D1 (de) 1998-10-22
EP0626383B1 (de) 1998-09-16
AU6059094A (en) 1994-10-27
CA2121613A1 (en) 1994-10-21
EP0626383A1 (de) 1994-11-30
JPH07118274A (ja) 1995-05-09
GB9308111D0 (en) 1993-06-02
US20020198379A1 (en) 2002-12-26
JP3489635B2 (ja) 2004-01-26
DE69413302T2 (de) 1999-05-20
US20020062023A1 (en) 2002-05-23
ATE171180T1 (de) 1998-10-15
ES2124844T3 (es) 1999-02-16

Similar Documents

Publication Publication Date Title
MX9702380A (es) Nuevas carboxamidas con actividad antifungica.
MX9702382A (es) Nuevos derivados de pirimidona con actividad antifungica.
PH30006A (en) 9-¬(Substituted glycol)amido¾-6.demethyl-6-deoxytetra-cyclines
OA09334A (fr) "Dérivés d'acides aminés".
CA2255951A1 (en) Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
BG101112A (en) The use of heterocyclic compounds
ZA954548B (en) Monoamine diamide thiol-containing metal chelating agents
AP9701041A0 (en) Pyridylpyrrole compounds.
MY110110A (en) Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
IL104891A0 (en) Cyclosporins,their preparation and pharmaceutical compositions containing them
AU697679B2 (en) Treatment of tinnitis using neuroprotective agents
NO996108L (no) 9-oksinerytromycinderivater
HU9302675D0 (en) Process for producing pharmaceutical compositions containing 21-norrapamycin as active agent
PE20001297A1 (es) Antibioticos cetolidos carbamato y carbazato
DE69631609D1 (en) Tricyclische erythromycinderivate
KR960703863A (ko) 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer)
CA2042934A1 (en) Treatment of ocular hypertension with an ocular synergistic combination
CA2192822A1 (en) Use of immunosuppressive agents for the treatment of schizophrenia
ZA942686B (en) Active compound from a sponge
YU46302A (sh) Supstituisani piroli
IL114646A0 (en) Method of inhibiting leukotriene biosynthesis